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twist toward better bone marrow engraftment?One of the major obstacles limiting the success of he-
matopoietic reconstitution appears to be the low efficiency
of hematopoietic stem cell (HSC) engraftment in the re-
cipient’s bone marrow. Among the key factors regulating
the hematopoietic reconstitution, the stromal-derived
factor-1 (SDF-1)/chemokine receptor CXCR4 axis has long
been known to be crucial due to its roles in HSC functions,
such as homing/mobilization, engraftment, and quies-
cence. The SDF-1/CXCR4-mediated marrow engraftment
processes have been mostly dissected through loss of
function experiments involving SDF-1/CXCR4 signals.1
There have been no previously published reports indi-
cating whether manipulation of the SDF-1/CXCR4 axis can
lead to enhanced HSC engraftment in a competitive trans-
plantation model using syngeneic mice. However, this
notion is about to change in view of a recent discovery by a
group of scientists from the NIH and several prominent
universities.2 While studying one of the first reported cases
of spontaneous remission of WHIM syndrome, a primary
immunodeficiency disease caused by autosomal dominant
gain-of-function CXCR4 mutations, this group of scientists,
led by Dr. Philip Murphy, observed that the deletion of the
mutant CXCR4 disease allele, together with another 163
genes from one copy of chromosome 2 in marrow HSC/
progenitors, led to durable myeloid reconstitution of the
patient’s bone marrow. The authors then demonstrated in
an analogous murine model that the loss of a CXCR4 WHIM
allele in mouse bone marrow conferred enhanced engraft-
ment compared with disease allele-bearing murine bone
marrow cells, thus confirming that deletion of the mutant
CXCR4 gene alone may have been sufficient to sustain the
HSC marrow engraftment and correct the WHIM phenotype
in the studied case. Further, the authors demonstrated thatPeer review under responsibility of Chongqing Medical
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itive advantage over wild type cells in mice. This seren-
dipitous discovery is certain to add a new twist to the
paradigm of the SDF-1/CXCR4 axis, while raising the pros-
pect of partial inactivation of CXCR4 as a novel strategy to
improve the outcomes of HSC transplantation.
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